We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksStandard Chartered Regulatory News (STAN)

Share Price Information for Standard Chartered (STAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 680.60
Bid: 680.80
Ask: 681.20
Change: 9.20 (1.37%)
Spread: 0.40 (0.059%)
Open: 677.20
High: 685.60
Low: 676.00
Prev. Close: 671.40
STAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SCPLC announces results of PRA stress test

1 Dec 2015 07:04

RNS Number : 4778H
Standard Chartered PLC
01 December 2015
 



 

 

1 December 2015

 

Standard Chartered PLC announces results of Prudential Regulation Authority stress test

 

Standard Chartered PLC, together with its subsidiaries, (the "Group") along with other UK based financial institutions has been subject to the 2015 stress test conducted by the Prudential Regulation Authority ("PRA"). The test is designed to assess the capital adequacy of the UK banking system based on the banks' balance sheets as at 31 December 2014. The results of the stress test were announced this morning. 

The PRA did not require the Group to submit a revised capital plan.

The test applied a hypothetical stress scenario to the Group's balance sheet as at 31 December 2014 and compared the theoretical Common Equity Tier 1 capital ("CET1 Capital") ratio and Tier 1 Leverage Ratio positions of the Group before and after the impact of strategic management actions.

One of the key areas of focus in the 2015 scenario was stresses arising from an economic slowdown in Asia. Details of the PRA's approach to the stress test and the detailed results in relation to all participating banks are available from the PRA website (http://www.bankofengland.co.uk/pra/Pages/default.aspx).

Result of stress test

The Group met both the CET1 Capital ratio and the Tier 1 Leverage Ratio requirements after the impact of strategic management actions.

The results of the stress test showed that the Group had a CET1 Capital ratio of 5.1 per cent. before the impact of strategic management actions, and 5.4 per cent. after the impact of strategic management actions, compared with the threshold CET1 Capital ratio of 4.5 per cent. 

The results of the stress test also showed that the Group had a Tier 1 Leverage Ratio of 2.8 per cent. before the impact of strategic management actions, and 3.0 per cent. after the impact of strategic management actions, compared with the 3 per cent. minimum Tier 1 Leverage Ratio requirement.

Standard Chartered believes that the results demonstrate the Group's resilience to a marked slowdown across the key markets in which it operates. 

The PRA judged that in the hypothetical stress scenario the Group's Tier 1 Capital Ratio after strategic management actions reduced to 5.9 per cent. which was below the Tier 1 minimum capital requirement of 6 per cent. This assessment did not include the AT1 capital issued by the Group in April 2015.

A number of actions taken since 31 December 2014 have strengthened the Group's capital and leverage position:

• The Group reported an increase in its CET1 Capital ratio from 10.7 per cent. at the start of 2015 to 11.5 per cent. as at 30 June 20151

 

• The Group issued US$2 billion of AT1 securities in April 2015 and reported an increase in its Tier 1 Leverage Ratio from 4.5 per cent. at the start of 2015 to 5.0 per cent. as at 30 June 20152

 

• The Group announced a fully underwritten 2 for 7 rights issue in November expected to raise GB£3.3 billion (net of expenses), or approximately US$5.1 billion3

In addition, the Rights Issue (as at 30 June 2015) would have on a pro forma basis increased the Group's CET1 Capital ratio to approximately 13.1 per cent., Tier 1 Leverage Ratio to approximately 5.6 per cent. and Tier 1 Capital Ratio to approximately 14.5 per cent.

The Group is operating with capital levels above current minimum regulatory requirements and has a number of additional levers at its disposal to further manage capital. 

Group Chief Executive, Bill Winters commented: 'We are pleased to have met the PRA stress test thresholds through a significant and prolonged stress scenario. The results of the test demonstrate our resilience to a marked slowdown across the key markets in which we operate. The test was conducted on our balance sheet as at the end of 2014. Since then we have made further significant progress in strengthening our capital position. We are operating at capital levels above current minimum regulatory requirements and have a number of additional levers at our disposal to further manage capital.'

Further details

Further information on the Group's financial performance will be available on 23 February 2016 when we issue our 2015 full year results.

Notes:

1As at 30 September 2015, the Group's CET1 Capital ratio was 11.4 per cent.2As at 30 September 2015, the Group's Tier 1 Leverage Ratio was 4.8 per cent.3Based on GB£1:US$1.5429 being the exchange rate as at 2 November 2015.

For further information, please contact:

James Hopkinson, Global Head of Investor Relations +44 (0)20 7885 7151

Sarah Lindgreen, Head of Group Media Relations +44 (0)20 7885 8764

- END -

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUAUVRVRAURRA
Date   Source Headline
23rd Apr 20245:50 pmRNSTransaction in Own Shares
22nd Apr 20245:40 pmRNSTransaction in Own Shares
19th Apr 20245:35 pmRNSTransaction in Own Shares
18th Apr 20245:35 pmRNSTransaction in Own Shares
17th Apr 20245:35 pmRNSTransaction in Own Shares
16th Apr 20245:35 pmRNSTransaction in Own Shares
15th Apr 20246:05 pmRNSTransaction in Own Shares
12th Apr 20244:54 pmRNSTransaction in Own Shares
12th Apr 20242:05 pmRNSNotice to ADR Holders of 6.409% Preference Shares
11th Apr 20245:45 pmRNSTransaction in Own Shares
10th Apr 20245:30 pmRNSTransaction in Own Shares
9th Apr 20246:05 pmRNSTransaction in Own Shares
8th Apr 20245:16 pmRNSTransaction in Own Shares
8th Apr 202411:32 amRNSNotice of AGM 2024 and Notice of Class Meeting
5th Apr 202410:30 amRNSOverseas Regulatory Announcement
4th Apr 20245:30 pmRNSTransaction in Own Shares
3rd Apr 20245:13 pmRNSTransaction in Own Shares
2nd Apr 20245:45 pmRNSTransaction in Own Shares
2nd Apr 202410:54 amRNSTotal Voting Rights
2nd Apr 20249:30 amRNSChanges to presentation of financial information
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:22 pmRNSNotice to ADR Holders of 6.409% Preference Shares
27th Mar 20245:39 pmRNSTransaction in Own Shares
26th Mar 20245:35 pmRNSTransaction in Own Shares
26th Mar 20244:36 pmRNSDirector/PDMR Shareholding
25th Mar 20245:43 pmRNSTransaction in Own Shares
22nd Mar 20245:35 pmRNSTransaction in Own Shares
21st Mar 20245:55 pmRNSTransaction in Own Shares
20th Mar 20245:30 pmRNSTransaction in Own Shares
20th Mar 20243:08 pmRNSDirector/PDMR Shareholding
19th Mar 20246:05 pmRNSTransaction in Own Shares
19th Mar 20245:45 pmRNSPublication of Final Terms
18th Mar 20245:51 pmRNSTransaction in Own Shares
15th Mar 20245:53 pmRNSTransaction in Own Shares
15th Mar 20244:45 pmRNSHolding(s) in Company
15th Mar 20244:30 pmRNSDirector/PDMR Shareholding
15th Mar 20243:35 pmRNSDirector/PDMR Shareholding
15th Mar 202410:30 amRNSHolding(s) in Company
14th Mar 20246:05 pmRNSTransaction in Own Shares
14th Mar 20242:03 pmRNSTotal Voting Rights
14th Mar 202411:05 amRNSDirector/PDMR Shareholding
13th Mar 20246:02 pmRNSTransaction in Own Shares
13th Mar 20246:00 pmRNSPublication of Supplementary Prospectus
13th Mar 202411:26 amRNSOverseas Regulatory Announcement – Grant of awards
13th Mar 202410:45 amRNSDirector/PDMR Shareholding
12th Mar 20246:00 pmRNSTransaction in Own Shares
12th Mar 20242:54 pmRNSDirector/PDMR Shareholding
12th Mar 202410:57 amRNSOverseas Regulatory Announcement - Grant of awards
12th Mar 202410:00 amRNSStandard Chartered: Management Team Change
11th Mar 20246:23 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.